Lowest Price Guaranteed From USD 4,799
Companies Covered
59
Pages
237
View Count
11941
The bioprocess automation market is estimated to be worth $3.8 billion in 2021 and is expected to grow CAGR of 12% during the forecast period. Over the past few decades, biopharmaceuticals have gained significant popularity owing to their therapeutic efficacy, favorable safety profiles and ability to treat a wide variety of disease indications, which are otherwise hard to treat. The success of these interventions has prompted the stakeholders to upgrade the conventional biologics manufacturing equipment. As a result, the domain has witnessed several technological advancements, including the adoption of controllers and automated systems. These systems not only ensure that the processes continue to run within precise limits but also make the necessary adjustments, while minimizing the risk of human errors and improving the product quality. Additionally, these controllers and automation systems have the potential to address a number of challenges associated with traditional bioprocessing systems and offer various additional benefits, such as lowering of production and labor cost (by 20-30%), optimizing the energy consumption (by 5-30%) and increasing the overall productivity (by 10-20%).
Given the various advantages of controllers and automated systems, biopharmaceutical developers and manufacturers are steadily adopting such solutions. Moreover, the recent surge in demand for vaccines amidst the ongoing COVID-19 pandemic has also prompted the biopharmaceutical companies to develop automation systems for producing drugs at a faster pace. In addition, several equipment manufacturers offering more user-friendly, controlled, and automated systems, have emerged. In fact, the field has been witnessing a lot of innovations, evident from the number of patents filed for the controllers and automation systems. These controllers and automated systems use process analytical technological tools that can be easily integrated in the bioprocessing unit to improve scalability. Stakeholders have also been focusing on making further improvements and have incorporated a variety of key features, including provisions for alerts / alarms, built-in system process control sensors, remote monitoring features, visual display, and advanced safety provisions. Owing to the rising interest of stakeholders towards technological advancement and adoption of these systems, we believe that the overall bioreactor controller and automation systems market is anticipated to witness substantial market growth during the forecast period.
Examples of key companies engaged in providing bioprocess controllers and automation software in the bioprocess automation market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Cytiva Lifesciences, Thermo Fisher Scientific, Sepragen, Repligen, Applikon Biotechnology, Sartorius, Solaris Biotech and Sysbiotech. This market report includes an easily searchable excel database of all the companies providing systems for bioprocess automation, worldwide.
Several recent developments have taken place in the field of bioprocess automation market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
![]() |
![]() |
![]() |
The “Bioprocess Automation Market By Type of Controllers (Upstream / Downstream Controller System and Bioprocess Control Software), Scale of Operation (Preclinical / Clinical Operations and Commercial Operations), Mode of Operation (Batch, Fed-Batch and Perfusion), Compatibility with Bioprocessing Systems (Single-Use Systems, and Stainless Steel / Other Systems), and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2035” market report features an extensive study of the current market landscape, market size, market share, market forecast, market outlook and future opportunities for the bioprocess automation market. The market research report also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in bioprocess automation market. In addition to other elements, the market research report includes:
The key objective of bioprocess automation market report is to provide a detailed market analysis in order to estimate the existing market size, market value, statistics and future opportunity for bioprocess automation market during the forecast period. Based on multiple parameters, such as overall bioprocessing equipment market, and adoption rate of automation systems, we have provided an informed estimate of the evolution of the market for the forecast period 2021-2035. Our year-wise projections of the current and future opportunity have further been segmented on the basis of [A] type of controllers (upstream controllers, downstream controller system and bioprocess control software), [B] scale of operation (preclinical / clinical operations and commercial operations), [C] mode of operation (batch, fed-batch and perfusion), [D] compatibility with bioprocessing systems (single-use systems, and stainless steel / other systems), and [E] key geographical regions (North America, Europe, Asia-Pacific and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
The opinions and insights presented in the market report are backed by a deep understanding of key insights generated from both secondary and primary research. The information presented in this market research report was also influenced by discussions held with senior stakeholders in this industry.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.
![]() |
![]() |
![]() |